Key result
An algorithm combining conjunctival blood velocity, NT-proBNP, and adiponectin discriminated patients with coronary artery disease from healthy controls with an AUROC of 0.967.
Why the study?
Microvascular haemodynamic alterations relate to CAD, but the non-invasively accessible conjunctival microcirculation had not been explored in clinical screening algorithms for CAD.
Does a novel algorithm combining conjunctival microcirculatory parameters and blood biomarkers accurately identify patients with coronary artery disease?
Case-Control (n=132)
Assessor-blinded
No
Does a novel algorithm combining conjunctival microcirculatory parameters and blood biomarkers accurately identify patients with coronary artery disease?
A novel, non-invasive screening algorithm combining conjunctival microcirculation hemodynamics and blood biomarkers demonstrated high diagnostic accuracy for identifying coronary artery disease.
Answers are grounded in this paper and cite their sources.
May support non-invasive CAD screening; leaves open prospective validation before clinical adoption.
Microvascular haemodynamic alterations are associated with coronary artery disease (CAD). The conjunctival microcirculation can easily be assessed non-invasively. However, the microcirculation of the conjunctiva has not been previously explored in clinical algorithms aimed at identifying patients with CAD. This case-control study involved 66 patients with post-myocardial infarction and 66 gender-matched healthy controls. Haemodynamic properties of the conjunctival microcirculation were assessed with a validated iPhone and slit lamp-based imaging tool. Haemodynamic properties were extracted with semi-automated software and compared between groups. Biomarkers implicated in the development of CAD were assessed in combination with conjunctival microcirculatory parameters. The conjunctival blood vessel parameters and biomarkers were used to derive an algorithm to aid in the screening of patients for CAD. Conjunctival blood velocity measured in combination with the blood biomarkers (N-terminal pro-brain natriuretic peptide and adiponectin) had an area under receiver operator characteristic curve (AUROC) of 0.967, sensitivity 93.0%, specificity 91.5% for CAD. This study demonstrated that the novel algorithm which included a combination of conjunctival blood vessel haemodynamic properties, and blood-based biomarkers could be used as a potential screening tool for CAD and should be validated for potential utility in asymptomatic individuals.
No takes yet. Share an insight, caveat, or question.
Awuah et al. (2022) conducted a case-control in Coronary artery disease (n=132). Algorithm combining conjunctival cross-sectional velocity, NT-proBNP, and adiponectin vs. Healthy controls was evaluated on Discrimination of post-MI patients from healthy controls (AUROC 0.967, p=<0.05). An algorithm combining conjunctival blood velocity, NT-proBNP, and adiponectin discriminated patients with coronary artery disease from healthy controls with an AUROC of 0.967.
Synapse has enriched 10 related papers. Consider them for comparative context: